BioTuesdays

Category - Markets

Immune Pharmaceuticals
Markets

Maxim starts Immune Pharma at buy; PT $3

Maxim Group launched coverage of Immune Pharmaceuticals (NASDAQ:IMNP) with a “buy” rating and $3 price target. The stock closed at 57 cents on Jan. 4. Immune’s bertilimumab is a monoclonal antibody (mAb), targeting...

January 5, 2018
Regulus Therapeutics Logo
Markets

Leerink starts Regulus Therapeutics at OP; PT $2

Leerink initiated coverage on Regulus Therapeutics (NASDAQ:RGLS) with an “outperform” rating and 12-month price target of $2. The stock closed at $1.18 on Jan. 4. “We believe that following numerous clinical setbacks...

January 5, 2018
UroGen Pharma
Markets

Ladenburg starts UroGen Pharma at buy; PT $50

Ladenburg Thalmann initiated coverage of UroGen Pharma (NASDAQ:URGN) with a “buy” rating and $50 price target. The stock closed at $37.21 on Dec. 29. UroGen is developing RTGel, a reverse, thermally-triggered hydrogel...

January 2, 2018
Genfit Logo
Markets

Roth starts Genfit at buy; PT €116

Roth Capital Partners launched coverage of Genfit (PSE:GNFT) with a “buy” rating and 12-month price target of €116. The stock closed at €22.09 on Dec. 20. “A spearhead in NASH drug development, Paris-based Genfit is...

December 21, 2017
Moleculin Logo
Markets

Roth starts Moleculin Biotech at buy; PT $8

Roth Capital Partners initiated coverage of Moleculin Biotech (NASDAQ:MBRX) with a “buy” rating and $8 price target. The stock closed at $1.69 on Dec. 20. “Our Moleculin bull thesis is based solely on its liposomal...

December 21, 2017
ConforMIS
Markets

BTIG ups ConforMIS to buy; PT $4

BTIG upgraded ConforMIS (NASDAQ:CFMS) to “buy” from “neutral” with a price target of $4. The stock was quoted at $2.58, up 30 cents, in afternoon trading on Dec. 20. ConforMIS designs and manufactures customized knee...

December 20, 2017
Organigram
Markets

Mackie ups Organigram price target to $5

Mackie Research raised its price target for Organigram Holdings (TSX:OGI) to $5 from $4 after the company completed a $57.5-million offering of units at a price of $3.50 a unit. The stock closed at $3.70 on Dec. 18...

December 19, 2017
Leerink Logo
Markets

Leerink outlines 2018 outlook of healthcare shares

Leerink is recommending that healthcare investors, after a market-beating 2017, look for ways to keep up with what will likely be a strong broader stock market in 2018. “We encourage use of higher-beta healthcare and...

December 18, 2017
Catalyst
Markets

Ladenburg ups Catalyst Bioscience PT to $14.25

Ladenburg Thalmann raised its price target for Catalyst Biosciences (NASDAQ:CBIO) to $14.25 from $11 after the company modified the Phase 1/2 protocol of CB 2679d that should accelerate the timeline to initiation of a...

December 18, 2017
Restoration Robotics
Markets

Roth starts Restoration Robotics at buy

Roth Capital Partners launched coverage of Restoration Robotics (NASDAQ:HAIR) with a “buy” rating and price target of $7.50. The stock closed at $4.86 on Dec. 15. Restoration is focused on developing and commercializing...

December 18, 2017